Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Incorporating mechanistic data into risk assessment.

Lois D Lehman-McKeeman1

  • 1Human Safety Department, Procter and Gamble Co., Cincinnati, OH, USA. lois.lehman-mckeeman@bms.com

Toxicology
|December 31, 2002
PubMed
Summary

This study demonstrates how to use mechanistic data to improve the scientific validity and reduce uncertainty in human risk assessment. Applying this approach enhances the accuracy of dose-response evaluations and inter-species extrapolation for chemicals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bicyclic Ligand-Biased Agonists of S1P<sub>1</sub>: Exploring Side Chain Modifications to Modulate the PK, PD, and Safety Profiles.

Journal of medicinal chemistry·2021
Same author

Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P<sub>1</sub>) Modulators: Optimization of the PK, PD, and Safety Profiles.

ACS medicinal chemistry letters·2020
Same author

Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Modulator Advanced into Clinical Trials.

Journal of medicinal chemistry·2019
Same author

Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulators.

MedChemComm·2018
Same author

Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model.

Obesity (Silver Spring, Md.)·2017
Same author

Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P<sub>1</sub> Receptor Modulator.

Journal of medicinal chemistry·2016

Area of Science:

  • Toxicology
  • Risk Assessment
  • Pharmacokinetics

Background:

  • Current risk assessment models often face uncertainty due to limited mechanistic understanding.
  • Mechanistic data offers a crucial link between molecular events and adverse outcomes.
  • Accurate dose-response and inter-species extrapolation rely on understanding mechanisms of action.

Purpose of the Study:

  • To illustrate the application of mechanistic data within established human risk assessment frameworks.
  • To demonstrate how mechanistic insights can enhance the scientific validity of risk analyses.
  • To provide a practical example for integrating mechanistic data into risk characterization.

Main Methods:

  • Utilized frameworks from the International Programme on Chemical Safety (IPCS) and the U.S. Environmental Protection Agency (USEPA).

Related Experiment Videos

  • Focused on key mechanistic data components to evaluate the strength and consistency of biological pathways.
  • Applied these mechanistic insights to refine human risk characterization.

    • Main Results:

    • Successfully integrated mechanistic data into the risk assessment process, improving scientific rigor.
    • Demonstrated a reduction in uncertainty by linking molecular events to adverse outcomes.
    • Showcased the utility of mechanistic data for robust dose-response and inter-species comparisons.

    Conclusions:

    • Incorporating mechanistic data significantly enhances the scientific validity of human risk assessment.
    • Mechanistic insights are critical for reducing uncertainty and improving the accuracy of regulatory decisions.
    • The presented framework provides a viable approach for applying mechanistic data in chemical risk evaluations.